Bronchial hyperresponsiveness

European Respiratory Monograph

Volumn 5, Issue 15, 2000, Pages 199-215

  Chinn, S ^a   Sunyer, J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Assessment; Bronchial hyperresponsiveness; Population; Reactivity; Sensitivity

Indexed keywords

ALLERGEN;

BRONCHUS HYPERREACTIVITY; CHILD; COMPARATIVE STUDY; CONCENTRATION RESPONSE; DOSE RESPONSE; HEALTH STATISTICS; HEALTH SURVEY; HUMAN; INCIDENCE; LUNG FUNCTION; MEASUREMENT; POPULATION RESEARCH; PREVALENCE; REPRODUCIBILITY; RESPIRATORY TRACT DISEASE; REVIEW; SENSITIZATION;

EID: 0033775173     PISSN: 1025448X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Airway Responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults
2. Airway response to carbachol in normal and asthmatic subjects
3. Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population
4. The distribution of bronchial responsiveness to histamine in symptomatic and asymptomatic subjects
5. Guidelines for standardization of bronchial challenge with (nonspecific) bronchoconstricting agents
6. Crise d'asthme experimental par aerosol de carbaminoylcholine chez l'homme, traitee par dispersat de phenylaminopropane
7. Hypersensibilite cholinergo-histaminique pulmonaire del l'asthmatique
8. Bronchial reactivity to inhaled histamine: A method and clinical survey
9. Rapid method for measurement of bronchial responsiveness
10. Histamine challenge testing: Comparison of three methods
11. Descriptive epidemiology of bronchial reactivity in an adult population: Results from a community study
12. Mesure de l'hyperreactivite bronchique epidemiologie
13. United Medical and Dental Schools of Guy's and St. Thomas Hospitals
14. Does nonspecific bronchial responsiveness indicate the severity of asthma?
15. Development of impaired lung function: Natural history and risk factors
16. Distribution of bronchial responsiveness in a general population; effect of sex, age, smoking, and level of pulmonary function
17. Bronchial responsiveness and symptoms in 5-6 year old children: A comparison of a direct and indirect challenge
18. An exercise challenge for epidemiological studies in childhood asthma; validity and repeatability
19. Reproducibility and comparison of responses to inhaled histamine and methacholine
20. Comparison of airway reactivity induced by histamine, methacholine, and isocapnic hyperventilation in normal and asthmatic subjects
21. Comparison of two epidemiological protocols for measuring airways responsiveness and allergic sensitivity in adults
22. Standardisation of bronchial inhalation challenge procedures
23. Understanding the clinical usefulness of airway hyperresponsiveness
24. A screening test for airways reactivity. An abbreviated methacholine inhalation challenge
25. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function
26. Lack of correlation between bronchoconstrictor response and bronchodilator response in a population-based study
27. Can measurements of airways responsiveness be standardized in children?
28. Methacholine challenge studies in a selected pediatric population
29. Reactivity to cold-air hyperventilation in normal and asthmatic children in a survey of 5,697 schoolchildren in Southern Bavaria
30. Nonpharmacological challenges in the assessment of bronchial responsiveness
31. An exercise challenge protocol for epidemiological studies of asthma in children: Comparison with histamine challenge
32. Adenosine, methacholine, and exercise challenges in children with asthma of paediatric chronic obstructive pulmonary disease
33. The shape of the dose-response curve to histamine in asthmatic and normal subjects
34. Limited bronchoconstriction to methacholine using partial flow-volume curves in nonasthmatic subjects
35. Variability of airway responses to inhaled histamine in normal subjects
36. Histamine dose-response curves in asthma: Reproducibility and sensitivity of different indices to assess response
37. Measurement of responsiveness to inhaled histamine using FEV1: Comparison of PC(20) and threshold
38. Histamine dose-response curves in asthma: Relevance of the distinction between PC(20) and reactivity in characterising clinical state
39. Slope of the dose-response curve: Usefulness in assessing bronchial responses to inhaled histamine
40. Slope of the dose-response curve to inhaled histamine and methacholine and PC(20) in subjects with symptoms of airway hyperexcitability and in normal subjects
41. Bronchial hyperresponsiveness: The need for a distinction between hypersensitivity and excessive airway narrowing
42. Variation in nebulizer aerosol output and weight output from the Mefar dosimeter: Implications for multi-centre studies
43. Summarizing methacholine bronchoprovocation data in epidemiological surveys
44. Estimation and repeatability of the response to inhaled histamine in a community survey
45. Evaluation of methacholine dose-response curves by linear and exponential mathematical models: Goodness-of-fit and validity of extrapolation
46. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS)
47. Concentrations of methacholine for bronchial responsiveness according to symptoms, smoking, and immunoglobulin E in a population-based study in Spain
48. Comparison of PD20 with two alternative measures of response to histamine challenge in epidemiological studies
49. Measuring change in logarithmic data, with special reference to bronchial responsiveness
50. Analysis of dose-response curves to methacholine
51. Analysis of bronchial reactivity in epidemiological studies
52. Relationships of bronchial responsiveness assessed by methacholine to serum IgE, lung function, symptoms, and diagnoses in 11-year-old New Zealand children
53. Individual allergens as risk factors for bronchial responsiveness in young adults
54. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam consultation on meta-analysis
55. Parental smoking, bronchial reactivity and peak expiratory flow variability in children
56. Histamine dose-response curves in asthma: Reproducibility and sensitivity of different indices to assess response
57. Histamine challenge testing: Comparison of three methods
58. A comparison of the Yan and a dosimeter method for methacholine challenge in experienced and inexperienced subjects
59. Comparison of histamine and methacholine challenge for use in bronchial challenge tests in community studies
60. Factors influencing the occurrence of airway hyperreactivity in the general population: The importance of atopy and airway calibre
61. Longitudinal analyses of airway responsiveness and pulmonary function decline
62. Seasonal variation in bronchial reactivity in a community population
63. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1
64. Measurement of bronchial reactivity: A question of interpretation
65. Indices of non-specific bronchial responsiveness in a paediatric population